Jon Hayashida - May 10, 2021 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role: VP, Global Clinical, Medical
Signature: /s/ Samuel Gesten as attorney-in-fact for Dr. Jon Hayashida
Stock symbol: STAA
Transactions as of: May 10, 2021
Transactions value $: -$1,036,156
Form type: 4
Date filed: 5/12/2021, 05:05 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STAA	Common Stock	Sale	-$169K	-1.35K	-13.92%	$125.22	8.34K	May 10, 2021	Direct	F1
transaction	STAA	Common Stock	Options Exercise	$116K	+7.2K	+86.31%	$16.15	15.5K	May 10, 2021	Direct
transaction	STAA	Common Stock	Options Exercise	$75.5K	+2.53K	+16.3%	$29.80	18.1K	May 10, 2021	Direct
transaction	STAA	Common Stock	Options Exercise	$125K	+3.46K	+19.15%	$35.98	21.5K	May 10, 2021	Direct
transaction	STAA	Common Stock	Options Exercise	$152K	+5.52K	+25.64%	$27.53	27.1K	May 10, 2021	Direct
transaction	STAA	Common Stock	Sale	-$1.34M	-10.8K	-39.76%	$124.13	16.3K	May 10, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STAA	Common Stock Options	Options Exercise	$0	-7.2K	-100%	$0.00^*	0	May 10, 2021	Common Stock	7.2K	$16.15	Direct	F3
transaction	STAA	Common Stock Options	Options Exercise	$0	-2.53K	-77.16%	$0.00	750	May 10, 2021	Common Stock	2.53K	$29.80	Direct	F4
transaction	STAA	Common Stock Options	Options Exercise	$0	-3.46K	-28.79%	$0.00	8.56K	May 10, 2021	Common Stock	3.46K	$35.98	Direct	F5
transaction	STAA	Common Stock Options	Options Exercise	$0	-5.52K	-36.11%	$0.00	9.77K	May 10, 2021	Common Stock	5.52K	$27.53	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.02 to $135.64, inclusive.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.85 to $135.64, inclusive.
F3	The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2028.
F4	The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2028.
F5	The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.
F6	The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.